Funder
Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Pernow, J.; Mahdi, A.; Yang, J.; Zhou, Z.: Red blood cell dysfunction: a new player in cardiovascular disease. Cardiovasc. Res. 115, 1596–1605 (2019)
2. Wernly, B.; Erlinge, D.; Pernow, J.; Zhou, Z.: Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling? Am. J. Physiol.-Heart Circu. Physiol. 320(1), H90–H94 (2021)
3. Husted, S.; Van Giezen, J.J.J.: Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc. Ther. 27, 259–274 (2009)
4. Khaleel, A.; Rohit, S.; Kashyap, P.; Anad, S.; Ambrish, S.: Ticagrelor: a new reversible oral antiplatelet agent. Int. Res. J. Pharm 1, 62–69 (2010)
5. Deeks, E.D.: Ticagrelor. Drugs 71, 909–933 (2011)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献